Similarity-Based Transcriptomic Modeling for Dynamic Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing genomic and proteomic data struggle with high dimensionality, noise, and dynamic expression changes, leading to inefficiencies in biomarker discovery and disease classification, particularly in cancer diagnosis and prognosis.
Innovation Solution
A model-based approach using similarity-based models that can detect both static and dynamic gene expression changes, capable of processing data quickly and robustly, allowing for interactive analysis and classification of disease states through autoassociative and inferential modeling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional statistical methods are used to analyze genomic data, then the analysis can be performed with simple algorithms, but the methods fail to capture dynamic expression changes and produce inaccurate results
Solution Approach 1:
The patent applies dynamics by using a dynamic Bayesian network that models gene expression as a time-varying process. The model incorporates temporal dependencies and allows expression levels to change dynamically across different conditions and time points, capturing the transient and adaptive nature of gene regulation rather than treating expression as static.
Solution Approach 2:
The patent implements parameter changes by allowing the Bayesian network parameters (probabilities and conditional dependencies) to vary across different experimental conditions, time points, and gene groups. This enables the model to adapt to changing biological states and capture condition-specific expression patterns.
2Loss of information
If complex analysis approaches are used to handle high-dimensional data, then more comprehensive patterns can be detected, but the methods become sensitive to noise and require large sample sizes
Solution Approach 1:
The patent applies segmentation by dividing the high-dimensional gene expression data into smaller, manageable groups or modules of co-regulated genes. This modular approach reduces the complexity of analysis while preserving important biological relationships, allowing the model to handle high-dimensional data without being overwhelmed by noise.
Solution Approach 2:
The patent uses copying by creating multiple replicated measurements or pseudo-replicates from limited biological samples through computational resampling techniques. This allows the model to learn robust patterns from insufficient data while maintaining reliability in the presence of noise.
3Stability of the object's composition
If standardized methods are used for data collection, then variability between experiments is reduced, but the ability to detect subtle dynamic changes is diminished
Solution Approach 1:
The patent resolves this contradiction by implementing a dynamic model that can handle variability between experiments while detecting subtle changes. The Bayesian framework incorporates uncertainty quantification and allows parameters to adapt to different experimental conditions, maintaining sensitivity to subtle dynamic changes even when experimental protocols vary.
4Reliability
If large sample sizes are used to improve statistical power, then more reliable patterns can be identified, but the cost and time required for data collection increase
Solution Approach 1:
The patent applies copying by using computational resampling and simulation techniques to generate multiple virtual replicates from limited biological samples. This computational approach provides the statistical power equivalent to large sample sizes without requiring actual collection of additional biological specimens, thereby reducing time and resource requirements.
Data Source
AI summary
An analytic apparatus and method is provided for diagnosis, prognosis and biomarker discovery using transcriptome data such as mRNA expression levels from microarrays, proteomic data, and metabolomic data. The invention provides for model-based analysis, especially using kernel-based models, and more particularly similarity-based models. Model-derived residuals advantageously provide a unique new tool for insights into disease mechanisms. Localization of models provides for improved model efficacy. The invention is capable of extracting useful information heretofore unavailable by other methods, relating to dynamics in cellular gene regulation, regulatory networks, biological pathways and metabolism.